Symbols

CANF

Can-fite Biopharma·AMEX

--(--)

CANF Profile

Can-Fite Biopharma Ltd.

A company that developing small molecule therapeutics to treat autoimmune-inflammatory, oncological and ophthalmic diseases

Industry

Pharmaceutical

Established Date

09/11/1994

Listing Date

11/19/2013

Exchange

American Stock Exchange

Full-time Employees

Fiscal Year Ends

12-31

Website

www.canfite.com

Security Type

Depository Receipts (Ordinary Shares)

Office address

26 Ben Gurion Street Ramat Gan 5257346 Israel

Business

Advanced clinical-stage biopharmaceutical company.

Introduction

Can-fite Biopharma Ltd., was founded on September 11, 1994. The company is a late-stage clinical biopharmaceutical company developing oral small molecule therapies targeting the A3 adenosine receptor for the treatment of cancer, liver and inflammatory diseases. Its main drug candidates include Piclidenoson for psoriasis and Namodenoson for hepatocellular carcinoma and metabolic dysfunction-associated steatohepatitis.